| 注册
首页|期刊导航|中国中医药信息杂志|护肾(Ⅲ)号胶囊中三七皂苷R1和人参皂苷Rg1在大鼠体内药代动力学研究

护肾(Ⅲ)号胶囊中三七皂苷R1和人参皂苷Rg1在大鼠体内药代动力学研究

钱伟 冯星月 陈晓峰 王建平 蒋志涛 余辉

中国中医药信息杂志2018,Vol.25Issue(7):71-74,4.
中国中医药信息杂志2018,Vol.25Issue(7):71-74,4.DOI:10.3969/j.issn.1005-5304.2018.07.017

护肾(Ⅲ)号胶囊中三七皂苷R1和人参皂苷Rg1在大鼠体内药代动力学研究

Pharmacokinetic Study on Notoginsenoside R1 and Ginsenoside Rg1 in Hushen (Ⅲ) Capsules in Rats

钱伟 1冯星月 1陈晓峰 1王建平 1蒋志涛 1余辉1

作者信息

  • 1. 南京中医药大学附属张家港医院,江苏省企业研究生工作站,江苏 张家港 215600
  • 折叠

摘要

Abstract

Objective To establish a UHPLC-MS/MS method for the determination of notoginsenoside R1 and ginsenoside Rg1 in rat plasma after oral administration of Hushen (Ⅲ) Capsules; To study its pharmacokinetics. Methods SD rats were given Hushen (Ⅲ) Capsules 2 g/kg and then the blood was collected at time point. Digoxin was used as internal standard. The drug concentrations of notoginsenoside R1 and ginsenoside Rg1 in plasma were determined by UHPLC-MS/MS. And the relative pharmacokinetic parameters were calculated by using DAS2.0 software. Results The linear relationship of notoginsenoside R1 and ginsenoside Rg1 was good (r≥0.997 5). The RSD of intra-day and inter-day precision were less than 13.1%. The results of accuracy, recovery and stability met the requirements for the biology sample analysis. For notoginsenoside R1, the pharmacokinetics parameters T1/2, Tmax, Cmaxin the plasma were (7.86±1.69)h, (4.00±1.04)h, (0.23±0.05)mg/L. For ginsenoside Rg1, the pharmacokinetics parameters T1/2, Tmax, Cmaxin plasma were (4.58±0.95)h, (6.00±0.00)h, (0.32±0.03)mg/L. Conclusion The established UHPLC-MS/MS method is sensitive, accurate and reliable, and is suitable for the pharmacokinetic study of Hushen (Ⅲ) Capsules.

关键词

护肾(Ⅲ)号胶囊/超高液相色谱串联质谱/药代动力学

Key words

Hushen (Ⅲ) Capsules/UHPLC-MS/MS/pharmacokinetics

分类

医药卫生

引用本文复制引用

钱伟,冯星月,陈晓峰,王建平,蒋志涛,余辉..护肾(Ⅲ)号胶囊中三七皂苷R1和人参皂苷Rg1在大鼠体内药代动力学研究[J].中国中医药信息杂志,2018,25(7):71-74,4.

基金项目

全国中药特色技术传承人才培训项目(2015年) (2015年)

中国中医药信息杂志

OACSCDCSTPCD

1005-5304

访问量0
|
下载量0
段落导航相关论文